Filing Flows › agilon health (AGL) › Guidance & outlook
agilon health (AGL) guidance and outlook
agilon health's 10-Q filed Nov 4, 2026 makes 5 forward-looking statements.
Guidance and outlook
Forward-looking statements, 10-Q filed Nov 4, 2026
- • our history of net losses and the expectation that our expenses will increase in the future;
- We will discuss and provide our analysis in the following order:
- Our platform support costs, which include regionally-based support personnel and other operating costs to support our geographies, are expected to decrease over time as a percentage of revenue as our physician partners add members and our revenue grows.
- We have based these estimates on assumptions that may prove to be wrong, and we could utilize our available capital resources sooner than we expect.
- If we do raise additional capital through public or private equity offerings, the ownership interest of our existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect our existing stockholders’ rights.
agilon health's latest quarter
agilon health, Q3 2026: revenue $1.5B (+6% year over year), operating margin 1.6%, net earnings $34.9M, operating cash flow $49.9M. The chart follows the revenue to costs, profit and cash.
Questions
What does agilon health expect?
• our history of net losses and the expectation that our expenses will increase in the future; We will discuss and provide our analysis in the following order: Our platform support costs, which include regionally-based support personnel and other operating costs to support our geographies, are expected to decrease over time as a percentage of revenue as our physician partners add members and our revenue grows.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.